Amphastar Pharmaceuticals (AMPH) Quick Ratio: History & Chart

Amphastar Pharmaceuticals, Inc.(AMPH)

Drug Manufacturers - Specialty & Generic · Rancho Cucamonga, CA

$25.16-0.21 (-0.81%)

Delayed quote: Oct 6, 2026, 10:05 AM EDT

About Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France. Amphastar's operations are divided into two primary segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API). The company's extensive product portfolio encompasses a variety of crucial medications. These feature Primatene Mist, an over-the-counter epinephrine inhaler for the temporary alleviation of mild asthma symptoms; Enoxaparin, a low molecular weight heparin utilized for the prevention and treatment of deep vein thrombosis; and Naloxone, an essential treatment for opioid overdose. Other significant offerings include emergency Glucagon injection kits; Cortrosyn, a diagnostic agent for adrenocortical insufficiency; and Amphadase, a bovine-sourced hyaluronidase injection that aids in the absorption and dispersion of other administered drugs. Amphastar additionally supplies Epinephrine injections for severe allergic reactions; various lidocaine products (such as a jelly for urological procedures and a topical solution for other applications); Phytonadione injection (Vitamin K1) for newborns; and specialized emergency syringe products for hospital use. Furthermore, the company provides Morphine injections for patient-controlled analgesia and Lorazepam injections for surgical and medical procedures. More advanced therapeutics consist of Neostigmine methylsulfate injection to manage myasthenia gravis and reverse muscle relaxant effects, and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Beyond its finished pharmaceutical goods, Amphastar also acts as a distributor for recombinant human insulin API and porcine insulin API. The company caters to a broad spectrum of healthcare providers, including hospitals, various care facilities, clinics, and physicians' offices.

Rancho Cucamonga, CA

1,976 employees

www.amphastar.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Yongfeng Zhang

View full financials

AMPH Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

1.71

QUICK RATIO (ACID-TEST) AVG TTM

2.37

QUICK RATIO (ACID-TEST) AVG 3Y

2.12

QUICK RATIO (ACID-TEST) AVG 5Y

2.24

QUICK RATIO (ACID-TEST) AVG 10Y

1.94

QUICK RATIO (ACID-TEST) AVG 15Y

N/A

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

-27.69%

CURRENT VS 3Y AVG

-19.06%

CURRENT VS 5Y AVG

-23.50%

CURRENT VS 10Y AVG

-11.59%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

2.99

median of 561 covered companies

CURRENT VS SECTOR MEDIAN

-42.69%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Amphastar Pharmaceuticals, Inc. (AMPH)	$1.11B	1.71	2.37	2.12	2.24
Castle Biosciences, Inc. (CSTL)vs ›	$1.11B	5.85	6.12	6.56	10.14
IRadimed Corporation (IRMD)vs ›	$1.10B	8.13	7.23	6.69	8.24
Bicara Therapeutics Inc. Common Stock (BCAX)vs ›	$1.12B	11.59	21.25	14.51	14.51
Harrow Health, Inc. (HROW)vs ›	$1.14B	2.08	2.01	3.15	3.64
GoodRx Holdings, Inc. (GDRX)vs ›	$1.16B	1.38	3.96	6.78	9.79
Avalyn Pharma Inc. Common Stock (AVLN)vs ›	$1.17B	33.10	10.19	10.19	10.19
Teladoc Health, Inc. (TDOC)vs ›	$1.04B	0.81	2.16	2.71	2.89
Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs ›	$1.03B	1.44	1.13	1.10	1.10
Damora Therapeutics, Inc. (DMRA)vs ›	$1.19B	19.73	13.53	9.78	15.63

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Amphastar Pharmaceuticals, Inc. (AMPH)

$1.11B

1.71

2.37

2.12

2.24

Castle Biosciences, Inc. (CSTL)vs ›

$1.11B

5.85

6.12

6.56

10.14

IRadimed Corporation (IRMD)vs ›

$1.10B

8.13

7.23

6.69

8.24

Bicara Therapeutics Inc. Common Stock (BCAX)vs ›

$1.12B

11.59

21.25

14.51

Harrow Health, Inc. (HROW)vs ›

$1.14B

2.08

2.01

3.15

3.64

GoodRx Holdings, Inc. (GDRX)vs ›

$1.16B

1.38

3.96

6.78

9.79

Avalyn Pharma Inc. Common Stock (AVLN)vs ›

$1.17B

33.10

10.19

Teladoc Health, Inc. (TDOC)vs ›

$1.04B

0.81

2.16

2.71

2.89

Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs ›

$1.03B

1.44

1.13

1.10

Damora Therapeutics, Inc. (DMRA)vs ›

$1.19B

19.73

13.53

9.78

15.63

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Amphastar Pharmaceuticals, Inc. (AMPH)?

The quick ratio (acid-test) for AMPH stock is 1.71.

Is Amphastar Pharmaceuticals, Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 1.71 is 24% below its 5-year average of 2.24, around the middle of its 5-year range (1.11–2.90).

What is the TTM average quick ratio (acid-test) for Amphastar Pharmaceuticals, Inc. (AMPH)?

The TTM average quick ratio (acid-test) for AMPH stock is 2.37.

What is the 3Y average quick ratio (acid-test) for Amphastar Pharmaceuticals, Inc. (AMPH)?

The 3Y average quick ratio (acid-test) for AMPH stock is 2.12.

What is the 5Y average quick ratio (acid-test) for Amphastar Pharmaceuticals, Inc. (AMPH)?

The 5Y average quick ratio (acid-test) for AMPH stock is 2.24.

What is the 10Y average quick ratio (acid-test) for Amphastar Pharmaceuticals, Inc. (AMPH)?

The 10Y average quick ratio (acid-test) for AMPH stock is 1.94.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	1.71
2026-03-31	2.82
2025-12-31	2.90
2025-09-30	2.21
2025-06-30	2.21
2025-03-31	2.02
2024-12-31	2.19
2024-09-30	2.61
2024-06-30	2.63
2024-03-31	1.72
2023-12-31	1.70
2023-09-30	1.68
2023-06-30	1.11
2023-03-31	2.88
2022-12-31	2.90
2022-09-30	2.75
2022-06-30	2.69
2022-03-31	2.35
2021-12-31	2.17
2021-09-30	2.08
2021-06-30	1.71
2021-03-31	1.60
2020-12-31	1.63
2020-09-30	1.73
2020-06-30	1.74
2020-03-31	1.67
2019-12-31	1.61
2019-09-30	1.84
2019-06-30	1.83
2019-03-31	1.35
2018-12-31	1.41
2018-09-30	1.34
2018-06-30	1.24
2018-03-31	1.53
2017-12-31	1.85
2017-09-30	1.86
2017-06-30	1.87
2017-03-31	1.55
2016-12-31	1.72
2016-09-30	1.64
2016-06-30	1.42
2016-03-31	1.40
2015-12-31	1.76
2015-09-30	1.79
2015-06-30	1.78
2015-03-31	1.63
2014-12-31	1.85
2014-09-30	2.02
2014-06-30	1.92
2014-03-31	1.35
2013-12-31	1.58
2013-09-30	1.61
2013-06-30	0.00
2013-03-31	0.00
2012-12-31	1.90

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

1.71

2026-03-31

2.82

2025-12-31

2.90

2025-09-30

2.21

2025-06-30

2.21

2025-03-31

2.02

2024-12-31

2.19

2024-09-30

2.61

2024-06-30

2.63

2024-03-31

1.72

2023-12-31

1.70

2023-09-30

1.68

2023-06-30

1.11

2023-03-31

2.88

2022-12-31

2.90

2022-09-30

2.75

2022-06-30

2.69

2022-03-31

2.35

2021-12-31

2.17

2021-09-30

2.08

2021-06-30

1.71

2021-03-31

1.60

2020-12-31

1.63

2020-09-30

1.73

2020-06-30

1.74

2020-03-31

1.67

2019-12-31

1.61

2019-09-30

1.84

2019-06-30

1.83

2019-03-31

1.35

2018-12-31

1.41

2018-09-30

1.34

2018-06-30

1.24

2018-03-31

1.53

2017-12-31

1.85

2017-09-30

1.86

2017-06-30

1.87

2017-03-31

1.55

2016-12-31

1.72

2016-09-30

1.64

2016-06-30

1.42

2016-03-31

1.40

2015-12-31

1.76

2015-09-30

1.79

2015-06-30

1.78

2015-03-31

1.63

2014-12-31

1.85

2014-09-30

2.02

2014-06-30

1.92

2014-03-31

1.35

2013-12-31

1.58

2013-09-30

1.61

2013-06-30

0.00

2013-03-31

0.00

2012-12-31

1.90

Quick Ratio (Acid-Test): 1.71

AMPH Quick Ratio

AMPH Average Quick Ratio (Acid-Test) Chart

AMPH Current vs Average Quick Ratio (Acid-Test) Chart

AMPH Quick Ratio (Acid-Test) Metrics

AMPH Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

AMPH Quick Ratio (Acid-Test) History

Related Metrics